Want to join the conversation?
Regenerative medicine company $MDXG reported a 31% increase in 1Q16 revenue when compared to a year ago. This revenue increase was helped by a YoverY growth in its Surgical, Sports Medicine and Orthopedics revenue of 28%, as well as a 32% growth in Wound Care revenue.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?